Prana Biotechnology Limited, a development stage company, through its subsidiaries, engages in the research and development of therapeutic drugs in Australia. It offers PBT-2, which is in Phase II a clinical trial, for patients with Alzheimer?s disease. The company?s products are designed to treat the underlying causes of degeneration of brain and eye as the aging process progresses. The company primarily focuses on Alzheimer?s disease. Prana Biotechnology Limited was incorporated in 1997 and is based in Parkville, Australia.